Insider · CIK 0001723092
Civik Thomas
Reports to the SEC for 4 companies · BOSTON, MA
Transactions
22
Companies
4
Filings
18
CIK
0001723092
Forms 4 and 5
Insider transactions
| Date | Company | Value |
|---|---|---|
| 2026-09-04 | PYXSPyxis Oncology, Inc. · Stock Option (Right to Buy)A Award | — |
| 2026-08-12 | PYXSPyxis Oncology, Inc. · Stock Option (Right to Buy)A Award | — |
| 2026-02-03 | PYXSPyxis Oncology, Inc. · Stock Option (Right to Buy)A Award | — |
| 2026-01-28 | RPTXRepare Therapeutics Inc.D Disposition to Issuer | — |
| 2025-03-31 | PYXSPyxis Oncology, Inc. · Stock Option (Right to Buy)A Award | +$36.2K |
| 2024-06-17 | RPTXRepare Therapeutics Inc. · Stock Option (right to buy)A Award | — |
| 2024-03-26 | PYXSPyxis Oncology, Inc. · Stock Option (Right to Buy)A Award | +$169K |
| 2023-06-08 | RPTXRepare Therapeutics Inc. · Stock Option (right to buy)A Award | — |
| 2023-03-24 | PYXSPyxis Oncology, Inc.A Award | — |
| 2022-05-13 | RPTXRepare Therapeutics Inc. · Stock Option (right to buy)A Award | — |
| 2022-03-31 | PYXSPyxis Oncology, Inc.A Award | — |
| 2021-11-18 | PYXSPyxis Oncology, Inc.P Purchase | +$200K |
| 2021-11-16 | RPTXRepare Therapeutics Inc.P Purchase | +$211K |
| 2021-10-07 | PYXSPyxis Oncology, Inc. · Stock Option (Right to buy)A Award | — |
| 2021-09-07 | RPTXRepare Therapeutics Inc. · Stock Option (right to buy)A Award | — |
| 2021-04-16 | FIVE PRIME THERAPEUTICS, INC.Employee Stock Option (right to buy)D Disposition to Issuer | — |
| 2021-04-16 | FIVE PRIME THERAPEUTICS, INC.D Disposition to Issuer | −$2.62M |
| 2021-04-09 | FIVE PRIME THERAPEUTICS, INC.F Tax Payment | −$421K |
| 2020-04-13 | FIVE PRIME THERAPEUTICS, INC.A Award | — |
| 2020-04-13 | FIVE PRIME THERAPEUTICS, INC.Employee Stock Option (right to buy)A Award | — |
| 2018-07-31 | Foundation Medicine, Inc.J Other | −$4.58M |
| 2018-01-01 | Foundation Medicine, Inc.A Award | +$2.28M |
Recent filings
- 4Civik Thomas0001193125-26-384391SEC(opens sec.gov)
- 4Civik Thomas0001193125-26-352206SEC(opens sec.gov)
- 4Civik Thomas0001193125-26-039951SEC(opens sec.gov)
- 4Civik Thomas0001723092-26-000002SEC(opens sec.gov)
- 4Civik Thomas0000950170-25-048894SEC(opens sec.gov)
- 4Civik Thomas0001415889-24-017654SEC(opens sec.gov)
- 4Civik Thomas0000950170-24-038098SEC(opens sec.gov)
- 4Civik Thomas0001209191-23-036298SEC(opens sec.gov)
- 4Civik Thomas0001209191-23-021404SEC(opens sec.gov)
- 4Civik Thomas0001209191-22-029370SEC(opens sec.gov)
- 4Civik Thomas0001140361-22-012919SEC(opens sec.gov)
- 4Civik Thomas0000899243-21-045363SEC(opens sec.gov)
- 4Civik Thomas0001209191-21-065517SEC(opens sec.gov)
- 4Civik Thomas0001140361-21-034427SEC(opens sec.gov)
- 4Civik Thomas0001209191-21-055321SEC(opens sec.gov)
- 4Civik Thomas0001209191-21-027390SEC(opens sec.gov)
- 4Civik Thomas0001209191-21-026419SEC(opens sec.gov)
- 4Civik Thomas0001209191-20-024363SEC(opens sec.gov)
Companies
Address
C/O PYXIS ONCOLOGY, INC. 321 HARRISON AVENUE, 11TH FL. SUITE 1
BOSTON, MA, 02118